Clinical, biochemical and molecular aspects of cerebellar ataxia and Coenzyme Q10 deficiency.
Coenzyme Q(10) (CoQ) deficiency is an autosomal recessive disorder presenting five phenotypes: a myopathic form, a severe infantile neurological syndrome associated with nephritic syndrome, an ataxic variant, Leigh syndrome and a pure myopathic form. The third is the most common phenotype related with CoQ deficiency and it will be the focus of this review. This new syndrome presents muscle CoQ deficiency associated with cerebellar ataxia and cerebellar atrophy as the main neurological signs. Biochemically, the hallmark of CoQ deficiency syndrome is a decreased CoQ concentration in muscle and/or fibroblasts. There is no molecular evidence of the enzyme or gene involved in primary CoQ deficiencies associated with cerebellar ataxia, although recently a family has been reported with mutations at COQ2 gene who present a distinct phenotype. Patients with primary CoQ deficiency may benefit from CoQ supplementation, although the clinical response to this therapy varies even among patients with similar phenotypes. Some present an excellent response to CoQ while others show only a partial improvement of some symptoms and signs. CoQ deficiency is the mitochondrial encephalomyopathy with the best clinical response to CoQ supplementation, highlighting the importance of an early identification of this disorder.
Montero
Raquel
R
Biochemistry, Hospital Sant Joan de Déu, Barcelona, Spain.
Pineda
Mercé
M
Aracil
Asun
A
Vilaseca
Maria-Antonia
MA
Briones
Paz
P
Sánchez-Alcázar
José-Antonio
JA
Navas
Plácido
P
Artuch
Rafael
R
D019883:Alkyl and Aryl Transferases / Q000235:genetics; D001284:Atrophy / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D002524:Cerebellar Ataxia / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology*; D002531:Cerebellum / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D003067:Coenzymes / Q000172:deficiency / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D028361:Mitochondrial Diseases / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000172:deficiency / Q000235:genetics
D003067:Coenzymes; D014451:Ubiquinone; D019883:Alkyl and Aryl Transferases; C021386:4-hydroxybenzoate polyprenyltransferase; C024989:coenzyme Q10